From Dow Jones & Company: The article challenges the widely-accepted belief that income inequality has drastically increased in the United

From Quiver Quantitative: The U.S. Department of Transportation is investigating major U.S. airlines’ frequent flyer programs for potential deceptive or

From Nasdaq: European stocks are expected to open lower as investors await the U.S. inflation reading. The Fed’s preferred inflation

From Dow Jones & Company: Chinese authorities have announced draft rules to crack down on spending and rewards in online

From Quiver Quantitative: Tesla’s highly anticipated Cybertruck is facing significant production delays due to challenges with manufacturing its innovative 4680

From Nasdaq: Indian shares opened on a positive note with the S&P BSE Sensex and NSE Nifty index both edging

From Dow Jones & Company: The article discusses a sudden and unexpected drop in the S&P 500 index, which occurred

From Barchart: Despite a recent rebound, Freeport-McMoRan stock is not performing as well as the overall markets in 2023. The

From Nasdaq: Nike Incorporated fiscal 2024 second-quarter conference call was led by Paul Trussell and included president and CEO, John

From Dow Jones & Company: U.S. stock markets rebounded on Thursday after a sharp selloff the previous day, with the

From Barchart: The article discusses the potential for dividend stocks to generate double-digit annualized returns in the future, using three

From Nielsen Holdings PLC: Indian shares may open with modest gains on Friday as new economic data from the U.S.

From Dow Jones & Company: In November, Japan’s overall consumer prices rose 2.8% from a year earlier, a decrease from

From StockStory: JFrog’s shares rose 6.2% after an analyst upgraded the stock’s rating to Buy and raised the price target.

From Nasdaq, Inc.: The Australian stock market is trading slightly higher on Friday despite negative cues from global markets. The

From Dow Jones & Company: The FDA has approved Wainua, developed by Ionis Pharmaceuticals and AstraZeneca, for the treatment of

From Stockstory: Mission Produce (NASDAQ:AVO) missed analysts’ revenue expectations in Q4 FY2023 with a 8.4% year on year increase to

From NasdaqomaX.: Soleno Therapeutics’ stock price received a 10% lift after a Guggenheim analyst raised the price target to $44

From Dow Jones & Company: In a recent interview, Elon Musk discussed his plans to turn X into a “giant

From Barchart: The article discusses the cyclical nature of the crude oil market, with changes in consumer demand driven by

From “Wall Street Journal”: Warner Bros. Discovery considering merging with Paramount Global, but no formal talks have begun. This follows

From Nasdaq: Canopy Growth (NASDAQ:CGC) saw a 13% drop in its stock price this week following a reverse-stock split and

From Dow Jones & Company: The article discusses how both stocks and bonds are heading for gains in 2023 after

From Barchart: On Thursday, the S&P 500 Index, Dow Jones Industrials Index, and Nasdaq 100 Index all closed higher, with

From Wall Street Journal: The major stock market indexes have shown consistent gains over the past seven weeks, marking a